Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
Date
2020Author
Sekine, Takuya
Perez-Potti, André
Rivera-Ballesteros, Olga
Strålin, Kristoffer
Baptiste Gorin, Jean
Olsson, Annika
Llewellyn-Lacey, Sian
Kamal, Habiba
Bogdanovic, Gordana
Muschiol, Sandra
Wullimann, David J.
Kammann, Tobias
Emgård, Johanna
Parrot, Tiphaine
Folkesson, Elin
Rooyackers, Olav
Eriksson, Lars I.
Henter, JanInge
Sönnerborg, Anders
Allander, Tobias
Albert, Jan
Nielsen, Morten
Klingström, Jonas
Gredmark-Russ, Sara
Björkström, Niklas K.
Sandberg, Johan K.
Price, David A.
Ljunggren, Hans-Gustaf
Aleman, Soo
Buggert, Marcus
Metadata
Show full item record
Documentos PDF
Abstract
SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune
protection against COVID-19. We here systematically mapped the functional and
phenotypic landscape of SARS-CoV-2-specific T cell responses in unexposed
individuals, exposed family members, and individuals with acute or convalescent
COVID-19. Acute phase SARS-CoV-2-specific T cells displayed a highly activated
cytotoxic phenotype that correlated with various clinical markers of disease severity,
whereas convalescent phase SARS-CoV-2-specific T cells were polyfunctional and
displayed a stem-like memory phenotype. Importantly, SARS-CoV-2-specific T cells
were detectable in antibody-seronegative exposed family members and convalescent
individuals with a history of asymptomatic and mild COVID-19. Our collective dataset
shows that SARS-CoV-2 elicits robust, broad and highly functional memory T cell
responses, suggesting that natural exposure or infection may prevent recurrent
episodes of severe COVID-19.
Palabras clave
COVID-19; Robust T; Cell immunityLink to resource
https://doi.org/10.1016/j.cell.2020.08.017Collections
Estadísticas Google Analytics
Comments
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.